|
⚲
|
| Keyboard |
| Versant Side Fund IV LP
✚
|
|
|---|---|
| CIK # | 0001456591 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001456591] | |
| 4 | [0001456591] | |
| SC 13G | [0001456591] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Versant Side Fund IV LP | Ophthotech Corp | [2018-11-09] |
| Versant Side Fund IV LP | Audentes Therapeutics Inc | [2017-02-14] |
| Versant Side Fund IV LP | Clovis Oncology Inc | [2012-02-10] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tempest Therapeutics Inc TPST
Common Stock
|
2024-08-12 | Sell | 387,999 | $1.10 | 426,799 |
|
Tempest Therapeutics Inc TPST
Common Stock
|
2024-08-08 | Sell | 400,000 | $1.35 | 540,000 |
|
Contineum Therapeutics Inc CTNM
Series B Preferred Stock · derivative
|
2024-04-09 | Conversion | 70,498 | ||
|
Contineum Therapeutics Inc CTNM
Series A Preferred Stock · derivative
|
2024-04-09 | Conversion | 298,975 | ||
|
Contineum Therapeutics Inc CTNM
Series A Preferred Stock · derivative
|
2024-04-09 | Conversion | 1,931 | ||
|
Contineum Therapeutics Inc CTNM
Series C Preferred Stock · derivative
|
2024-04-09 | Conversion | 275,769 | ||
|
Contineum Therapeutics Inc CTNM
Series C Preferred Stock · derivative
|
2024-04-09 | Conversion | 689 | ||
|
Contineum Therapeutics Inc CTNM
Series C Preferred Stock · derivative
|
2024-04-09 | Conversion | 110,187 | ||
|
Contineum Therapeutics Inc CTNM
Series B Preferred Stock · derivative
|
2024-04-09 | Conversion | 317,988 | ||
|
Contineum Therapeutics Inc CTNM
Series B Preferred Stock · derivative
|
2024-04-09 | Conversion | 434,725 | ||
|
Contineum Therapeutics Inc CTNM
Series B Preferred Stock · derivative
|
2024-04-09 | Conversion | 2,182 | ||
|
Contineum Therapeutics Inc CTNM
Series B Preferred Stock · derivative
|
2024-04-09 | Conversion | 348,143 | ||
|
Contineum Therapeutics Inc CTNM
Series A-1 Preferred Stock · derivative
|
2024-04-09 | Conversion | 1,423,119 | ||
|
Contineum Therapeutics Inc CTNM
Series A Preferred Stock · derivative
|
2024-04-09 | Conversion | 9,252 | ||
|
Contineum Therapeutics Inc CTNM
Series A Preferred Stock · derivative
|
2024-04-09 | Conversion | 1,476,446 | ||
|
Contineum Therapeutics Inc CTNM
Series C Preferred Stock · derivative
|
2024-04-09 | Conversion | 57,565 | ||
|
Contineum Therapeutics Inc CTNM
Series C Preferred Stock · derivative
|
2024-04-09 | Conversion | 145 | ||
|
Contineum Therapeutics Inc CTNM
Series C Preferred Stock · derivative
|
2024-04-09 | Conversion | 22,312 | ||
|
Contineum Therapeutics Inc CTNM
Series B Preferred Stock · derivative
|
2024-04-09 | Conversion | 90,747 | ||
|
Contineum Therapeutics Inc CTNM
Class A Common Stock
|
2024-04-09 | Conversion | 2,531 | ||
| showing 20 of 105 most recent transactions | |||||